Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database
- PMID: 33080630
- PMCID: PMC7869035
- DOI: 10.1055/a-1272-3788
Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database
Erratum in
-
Correction: Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database.Endoscopy. 2021 Feb;53(2):C11. doi: 10.1055/a-1695-5719. Epub 2021 Nov 17. Endoscopy. 2021. PMID: 34788871 Free PMC article. No abstract available.
Abstract
Background: COVID-19 has dramatically affected gastrointestinal endoscopy practice. We aimed to investigate its impact on procedure types, indications, and findings.
Methods: We retrospectively analyzed endoscopies performed in 15 Dutch hospitals by comparing periods 15 March to 25 June of 2019 and 2020 using the prospective Trans.IT database.
Results: During lockdown in 2020, 9776 patients underwent endoscopy compared with 19 296 in 2019. Gastroscopies decreased by 57 % (from 7846 to 4467) and colonoscopies by 45 % (from 12219 to 5609), whereas endoscopic retrograde cholangiopancreatography volumes remained comparable (from 578 to 522). Although endoscopy results indicative of cancer decreased (from 524 to 340), the likelihood of detecting cancer during endoscopy increased (2.7 % [95 % confidence interval (CI) 2.5 - 3.0] in 2019 versus 3.5 % [95 %CI 3.1 - 3.9] in 2020; P < 0.001). After lifting of lockdown, endoscopy volumes started to return to normal, except for colorectal cancer screening.
Conclusions: Fewer endoscopies were performed during the COVID-19 lockdown, leading to a significant reduction in the absolute detection of cancer. Endoscopies increased rapidly after lockdown, except for colorectal cancer screening.
Thieme. All rights reserved.
Conflict of interest statement
Prof. Bruno is a consultant for and has received support for industry- and investigator-initiated studies from Boston Scientific and Cook Medical. He has also received support for investigator-initiated studies from Pentax Medical, Mylan, and ChiRoStim. Dr. Ouwendijk has received research grants from Janssen Netherlands, Olympus, and the Coolsingel Foundation. Prof. Siersema has received research grants from Norgine, Pentax, Microtech, Yakult, and Motus GI (ongoing), and is an advisory board member for Motus GI. All other authors declare that they have no conflicts of interest.
Figures


Comment in
-
Endoscopy during COVID – what have we learned?Endoscopy. 2021 Feb;53(2):171-172. doi: 10.1055/a-1327-2386. Epub 2021 Jan 27. Endoscopy. 2021. PMID: 33503667 Free PMC article. German. No abstract available.
-
Author commentary on Marten A. Lantinga et al.Endoscopy. 2021 Feb;53(2):v9. doi: 10.1055/a-1287-4904. Epub 2021 Jan 27. Endoscopy. 2021. PMID: 33503668 Free PMC article. No abstract available.
References
-
- Medicine JHUo Coronavirus Resource Center COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) Baltimore: Johns Hopkins University of Medicine; https://coronavirus.jhu.edu/map.htmlLast accessed September 2020
-
- National Institute for Health and Environment Ministry of Health, Welfare and Sport. COVID-19 (novel coronavirus) https://www.rivm.nl/Last accessed September 2020